A Participatory Approach Involving Patients with Cystic Fibrosis and Healthcare Professionals for the Co-Design of an Adherence-Enhancing Intervention Toolkit

Autor: Viprey M, Mougeot F, Dima AL, Haesebaert J, Occelli P, Durieu I, Rouzé H, Reynaud Q, Touzet S

Publikováno v: Patient Preference and Adherence, Vol Volume 17, Pp 995-1004 (2023)

Marie Viprey,1,2 Frédéric Mougeot,3 Alexandra Lelia Dima,2,4 Julie Haesebaert,2,5 Pauline Occelli,2,5 Isabelle Durieu,2,6 Héloïse Rouzé,2,5 Quitterie Reynaud,2,6 Sandrine Touzet2,7 1Hospices Civils de Lyon, Pôle Santé Publique, Service des Don

Externí odkaz: https://doaj.org/article/68afb536bef94baf8b1576f01cbb91a4

Papillomavirus humain et lupus érythémateux systémique

Autor: David, E. ^*, Belot, A., Lega, J.-C., Durieu, I., Rousset-Jablonski, C.

Publikováno v: In La revue de médecine interne July 2021 42(7):498-504

Presence of anti-CCP2 and anti-DNA antibodies: clinical features of 79 patients.

Autor: Tabary A; Department of Internal Medicine, Hôpital Lyon Sud, Hospices Civils de Lyon, Université Claude Bernard Lyon 1, Pierre-Bénite, France. Electronic address: axeltabary@gmail.com., Coutant F; Immunogenomics and Inflammation Research Team, Hôpital Edouard Herriot, Hospices Civils de Lyon, Lyon, France; Immunology Department, Hôpital Lyon Sud, Hospices Civils de Lyon, Université Claude Bernard Lyon 1, Pierre-Bénite, France., Subtil F; Service de Biostatistique, Hospices Civils de Lyon, Lyon, France; Université de Lyon, Université Lyon 1, CNRS, Laboratoire de Biométrie et Biologie Évolutive UMR 5558, Villeurbanne, France., Sève P; Department of Internal Medicine, Hôpital de la Croix-Rousse, Hospices Civils de Lyon, Université Claude Bernard Lyon 1, Lyon, France; Research on Healthcare Performance (RESHAPE), INSERM U1290, University Claude Bernard Lyon 1, 69100 Lyon, France., Hot A; Department of Internal Medicine, Hôpital Edouard Herriot, Hospices Civils de Lyon, Université Claude Bernard-Lyon 1, Lyon, France., Confavreux C; Bone Metastases Expert Center CEMOS, Department of Rheumatology, Hôpital Lyon Sud, Hospices Civils de Lyon, Pierre-Bénite, France; INSERM UMR 1033, Université Claude Bernard Lyon 1, Hôpital Edouard Herriot, Lyon, France., Chapurlat R; INSERM UMR 1033, Université Claude Bernard Lyon 1, Hôpital Edouard Herriot, Lyon, France; Bone Disease and Rheumatology Department, Reference Centre for Fibrous Dysplasia, Hôpital Edouard Herriot, Hospices Civils de Lyon, France., Fabien N; Immunology Department, Hôpital Lyon Sud, Hospices Civils de Lyon, Université Claude Bernard Lyon 1, Pierre-Bénite, France., Richard M; Department of Internal Medicine, Hôpital Lyon Sud, Hospices Civils de Lyon, Université Claude Bernard Lyon 1, Pierre-Bénite, France., Grienay N; Department of Internal Medicine, Hôpital Lyon Sud, Hospices Civils de Lyon, Université Claude Bernard Lyon 1, Pierre-Bénite, France., Roubertou Y; Department of Internal Medicine, Hôpital Lyon Sud, Hospices Civils de Lyon, Université Claude Bernard Lyon 1, Pierre-Bénite, France., Durieu I; Department of Internal Medicine, Hôpital Lyon Sud, Hospices Civils de Lyon, Université Claude Bernard Lyon 1, Pierre-Bénite, France; Research on Healthcare Performance (RESHAPE), INSERM U1290, University Claude Bernard Lyon 1, 69100 Lyon, France., Reynaud Q; Department of Internal Medicine, Hôpital Lyon Sud, Hospices Civils de Lyon, Université Claude Bernard Lyon 1, Pierre-Bénite, France; Research on Healthcare Performance (RESHAPE), INSERM U1290, University Claude Bernard Lyon 1, 69100 Lyon, France. Electronic address: quitterie.reynaud@chu-lyon.fr.

Publikováno v: Joint bone spine [Joint Bone Spine] 2024 Dec 21, pp. 105834. Date of Electronic Publication: 2024 Dec 21.

One year of ETI reduces lung bacterial colonisation in adults with cystic fibrosis.

Autor: Mianowski L; Centre de référence Adulte de la Mucoviscidose, Service de médecine interne, Hospices civils de Lyon, Pierre Bénite, France., Doléans-Jordheim A; Institut des agents infectieux, Hospices Civils de Lyon, Lyon, France.; Centre de recherche International en infectiologie, INSERM U1111 Université Claude Bernard Lyon 1, CNRS UMR 5308 Ecole Normale Supérieure de Lyon, Lyon, France., Barraud L; Service de Biostatistique et Bioinformatique, Hospices Civils de Lyon, Lyon, F-69003, France., Rabilloud M; Service de Biostatistique et Bioinformatique, Hospices Civils de Lyon, Lyon, F-69003, France.; Laboratoire de Biométrie et Biologie Evolutive, CNRS, UMR 5558, Equipe Biostatistique-Santé, Villeurbanne, F-69100, France., Richard M; Centre de référence Adulte de la Mucoviscidose, Service de médecine interne, Hospices civils de Lyon, Pierre Bénite, France., Josserand RN; Centre de référence Adulte de la Mucoviscidose, Service de médecine interne, Hospices civils de Lyon, Pierre Bénite, France., Durieu I; Centre de référence Adulte de la Mucoviscidose, Service de médecine interne, Hospices civils de Lyon, Pierre Bénite, France.; RESearch on HealthcAre PErformance (RESHAPE), INSERM U1290, Université Claude Bernard Lyon 1, Lyon , France.; ERN-Lung CF network, Frankfurt, Germany., Reynaud Q; Centre de référence Adulte de la Mucoviscidose, Service de médecine interne, Hospices civils de Lyon, Pierre Bénite, France. quitterie.reynaud@chu-lyon.fr.; RESearch on HealthcAre PErformance (RESHAPE), INSERM U1290, Université Claude Bernard Lyon 1, Lyon , France. quitterie.reynaud@chu-lyon.fr.; ERN-Lung CF network, Frankfurt, Germany. quitterie.reynaud@chu-lyon.fr.

Publikováno v: Scientific reports [Sci Rep] 2024 Nov 26; Vol. 14 (1), pp. 29298. Date of Electronic Publication: 2024 Nov 26.

Comparison of prognostic scores according to WHO classification in 170 patients with advanced mastocytosis and C-finding treated with midostaurin.

Autor: Heiblig M; Hematology Department, Centre Hospitalier Lyon Sud, Pierre-Bénite, France., Gourguechon C; Department of Hematology, Amiens University Hospital, Amiens, France., Guilpain P; CEREMAST, the Department of Internal Medicine-Multi-organ Diseases, Saint-Eloi University Hospital, Montpellier University, Montpellier, France., Bulai-Livideanu C; CEREMAST Toulouse, Dermatology Departmen, CHU de Toulouse, Toulouse, France., Barete S; Sorbonne Université, APHP, Unité Fonctionnelle de Dermatologie, Groupe Hospitalier Pitié-Salpêtrière-C. Foix, Paris, France.; French Reference Center for Mastocytosis (CEREMAST), Necker-Enfants Malades University Hospital, APHP, Paris, France., Chantran Y; Department of Biological Hematology, Pitié-Salpêtrière Hospital, DMU BioGem, AP-HP, Sorbonne University, Paris, France.; Department of Biological Immunology, Saint-Antoine Hospital, DMU BioGem, AP-HP, Sorbonne University, Paris, France.; Health Environmental Risk Assessment (HERA) Team, Centre of Research in Epidemiology and Statistics (CRESS), Inserm/INRAE, Faculty of Pharmacy, Université de Paris, Paris, France., Agopian J; Association Française pour les Initiatives de Recherche sur le Mastocyte et les Mastocytoses (AFIRMM), Paris, France., Brenet F; Centre de Recherche en Cancérologie de Marseille (CRCM) INSERM U1068, CNRS UMR7258, AMU U105, Département d'Onco-Hématologie-Immunologie, Institut Paoli-Calmettes, Marseille, France., Dubreuil P; Centre de Recherche en Cancérologie de Marseille (CRCM) INSERM U1068, CNRS UMR7258, AMU U105, Département d'Onco-Hématologie-Immunologie, Institut Paoli-Calmettes, Marseille, France., Lespinasse J; eXYSTAT, Malakoff, France., Lemal R; Adult Clinical Hematology, Clermont-Ferrand University Hospital, INSERM CIC501, EA 7453-Université Clermont Auvergne, Clermont-Ferrand, France., Tournilhac O; Adult Clinical Hematology, Clermont-Ferrand University Hospital, INSERM CIC501, EA 7453-Université Clermont Auvergne, Clermont-Ferrand, France., Terriou L; INSERM, CHU Lille, Department of Internal Medicine and Clinical Immunology, U1286 - INFINITE - Institute for Translational Research in Inflammation, University Lille, Lille, France., Launay D; INSERM, CHU Lille, Service de Médecine Interne et Immunologie Clinique, Centre de référence des maladies autoimmunes systémiques rares du Nord et Nord-Ouest de France (CeRAINO), U1286 - INFINITE - Institute for Translational Research in Inflammation, University Lille, Lille, France., Bouillet L; Internal Medicine Department, Grenoble Alpes University Hospital, Univ. Grenoble Alpes, T-RAIG unit, CNRS, UMR 5525, VetAgro Sup, Grenoble INP, CHU Grenoble Alpes, TIMC, Grenoble, France., Chatain C; Internal Medicine Department, Grenoble Alpes University Hospital, Univ. Grenoble Alpes, T-RAIG unit, CNRS, UMR 5525, VetAgro Sup, Grenoble INP, CHU Grenoble Alpes, TIMC, Grenoble, France., Damaj G; Haematology Institute, Normandy University School of Medicine, Caen, France., Ballul T; French Reference Center for Mastocytosis (CEREMAST), Necker-Enfants Malades University Hospital, APHP, Paris, France.; Imagine Institute, INSERM U1163, Necker-Enfants Malades University Hospital, Paris University, Paris, France., Greco C; CEREMAST, the Department of Pain and Palliative Care Unit, Necker-Children's Hospital, AP-HP, Paris Centre University, Paris, France., Polivka L; Haematology Institute, Normandy University School of Medicine, Caen, France.; Department of Dermatology, Reference Center for Genodermatoses (MAGEC), Necker Hospital for Sick Children, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris Cité University, Paris, France.; CEREMAST, the Department of Hematology, Necker-Children's Hospital, AP-HP, Paris Centre University, Paris, France., Frenzel L; French Reference Center for Mastocytosis (CEREMAST), Necker-Enfants Malades University Hospital, APHP, Paris, France.; Imagine Institute, INSERM U1163, Necker-Enfants Malades University Hospital, Paris University, Paris, France., Meni C; French Reference Center for Mastocytosis (CEREMAST), Necker-Enfants Malades University Hospital, APHP, Paris, France., Bouktit H; French Reference Center for Mastocytosis (CEREMAST), Necker-Enfants Malades University Hospital, APHP, Paris, France., Benabou D; French Reference Center for Mastocytosis (CEREMAST), Necker-Enfants Malades University Hospital, APHP, Paris, France., Gaudy-Marqueste C; Dermatology and Skin Cancer, Department, Aix-Marseille University, APHM, Marseille, France., Gousseff M; Department of Internal Medicine, Bretagne Atlantique Hospital, Vannes, France., Le Mouel E; Department of Internal Medicine and Clinical Immunology, Rennes University Hospital, Rennes, France., Neel A; CEREMAST, the Department of Internal Medicine, Hôtel-Dieu University Hospital, Nantes, France., Ranta D; Department of Haematology, Nancy University Hospital, Nancy, France., Jaussaud R; Department of Internal Medicine and Clinical Immunology, Vandoeuvre-lès-Nancy, France., Molina TJ; Department of pathology, Necker-Children's Hospital, AP-HP, Paris Centre University, Paris, France., Bruneau J; Imagine Institute, INSERM U1163, Necker-Enfants Malades University Hospital, Paris University, Paris, France.; Department of pathology, Necker-Children's Hospital, AP-HP, Paris Centre University, Paris, France., Villarese P; Laboratory of Onco-Hematology, Necker Children's Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France., Lhermitte L; Laboratory of Onco-Hematology, Necker Children's Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France.; CNRS, INSERM U1151, Institut Necker Enfants Malades (INEM), Université Paris Cité, Paris, France., Maouche-Chrétien L; Imagine Institute, INSERM U1163, Necker-Enfants Malades University Hospital, Paris University, Paris, France., Temple M; Hematology Laboratory, Assistance Publique-Hôpitaux de Paris, Cochin Hospital, Paris, France.; INSERM U1016, Université de Paris, Institut Cochin, Paris, France., Kosmider O; Hematology Laboratory, Assistance Publique-Hôpitaux de Paris, Cochin Hospital, Paris, France.; INSERM U1016, Université de Paris, Institut Cochin, Paris, France., Javier RM; Rheumatology Department, Competence Center for Rare Genetic Bone Disorders, University-Hospital of Strasbourg, Strasbourg, France., Pelletier F; CEREMAST, the Department of Dermatology, Allergology Unit, University Hospital of Besançon, Besançon, France., Castelain F; Unité Transversale Allergologie, Dermatologie, CHU Besançon - Université de Franche-Comté, EFS, INSERM, UMR RIGHT, Besançon, France., Retornaz F; Unité de soins et de recherche en médecine interne et maladies infectieuses, European Hospital, Marseille, France., Cabrera Q; Department of Haematology, Sud Reunion University Hospital, Saint Pierre, France., Zunic P; Department of Haematology, Sud Reunion University Hospital, Saint Pierre, France., Gourin MP; CEREMAST, the Department of Hematology, CHU Dupuytren, Limoges, France., Wierzbicka-Hainaut E; CEREMAST, the Department of Dermatology, CHU de Poitiers, Poitiers, France., Viallard JF; Department of Internal Medicine, Hôpital Haut-Lévêque, Université de BORDEAUX, Pessac, France., Lavigne C; Department of Internal Medicine, Angers University Hospital, Angers, France., Hoarau C; The Service d'Immunologie Clinique et d'Allergologie, Centre Hospitalier Régional Universitaire, Tours, France., Durieu I; Internal Medicine Department, Centre Hospitalier Lyon Sud, Pierre-Bénite, France.; INSERM U1290, Université Lyon 1, Lyon, France., Dimicoli-Salazar S; Department of Hematology, CHU de Bordeaux, Bordeaux, France., Torregrosa-Diaz JM; Service d'hématologie Oncologique et Thérapie Cellulaire, CIC-1402, CHU de Poitiers, Poitiers, France., Wemeau M; Department of Haematology, Hospital Centre of Roubaix, Roubaix, France., Soria A; Department of Dermatology and Allergy, Tenon Hospital, Sorbonne University, Paris, France., Arock M; Platform of Molecular Analysis for Mastocytosis and MCAD (CEREMAST), Department of Biological Hematology, Pitié-Salpêtrière Hospital, AP-HP, Paris Sorbonne University, Paris, France., Bodemer C; Department of Dermatology, Reference Center for Genodermatoses (MAGEC), Necker Hospital for Sick Children, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris Cité University, Paris, France.; CEREMAST, the Department of Hematology, Necker-Children's Hospital, AP-HP, Paris Centre University, Paris, France., Lortholary O; French Reference Center for Mastocytosis (CEREMAST), Necker-Enfants Malades University Hospital, APHP, Paris, France., Hermine O; French Reference Center for Mastocytosis (CEREMAST), Necker-Enfants Malades University Hospital, APHP, Paris, France.; CEREMAST, the Department of Pain and Palliative Care Unit, Necker-Children's Hospital, AP-HP, Paris Centre University, Paris, France., Rossignol J; French Reference Center for Mastocytosis (CEREMAST), Necker-Enfants Malades University Hospital, APHP, Paris, France.; Imagine Institute, INSERM U1163, Necker-Enfants Malades University Hospital, Paris University, Paris, France.

Publikováno v: American journal of hematology [Am J Hematol] 2024 Nov; Vol. 99 (11), pp. 2127-2139. Date of Electronic Publication: 2024 Sep 17.